DaVita (DVA) director reports 411-share stock acquisition
DaVita Inc. director reports a small stock acquisition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DaVita Inc. director reports a small stock acquisition. A director of DaVita Inc. (DVA) acquired 411 shares of common stock on 11/15/2025 at a reported price of $0 per share, indicating this was likely an equity grant rather than an open-market purchase. Following this transaction, the director beneficially owns 5,110 shares of DaVita common stock, held directly. No derivative securities such as options or warrants are reported as acquired or disposed of in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 411 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did DaVita (DVA) report in this Form 4?
A DaVita Inc. director reported acquiring 411 shares of DaVita common stock on 11/15/2025, according to the Form 4 filing.
Does the DaVita (DVA) Form 4 report any derivative securities like options or warrants?
The filing’s Table II for derivative securities shows no reported acquisitions or dispositions of options, warrants, or other derivative instruments.
What role does the reporting person have at DaVita (DVA)?
The reporting person is identified as a director of DaVita Inc. in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.